New drug tested for painful skin condition
Disease control
Recruiting now
This study is testing if an experimental drug called NAV-240 works better than a placebo to reduce painful skin bumps and tunnels in adults with moderate-to-severe hidradenitis suppurativa (HS). About 150 participants will receive either one of two doses of NAV-240 or a placebo t…
Phase: PHASE2 • Sponsor: Navigator Medicines, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC